FENSOME ANDREW
No ORCID on file
· 513 papers in corpus
· active 2000-2011
Frequent coauthors
- MCCOMAS CASEY CAMERON 270
- MARELLA MICHAEL ANTHONY 207
- GRUBB Gary S. 207
- MELENSKI EDWARD GEORGE 189
- COMMONS THOMAS JOSEPH 171
- JONES Todd K. 162
- EDWARDS James P. 162
- TEGLEY Christopher M. 162
- HEFFERNAN GAVIN DAVID 162
- WEBB MICHAEL BYRON 153
2011
Disclosed herein are oxazolidone compounds of the given formula wherein the substituents are as defined within the specification. Said compounds are useful for treating hormone-related conditions including contraception, treating or prevent…
2011
Disclosed herein are oxazolidone compounds of the given formula wherein the substituents are as defined within the specification. Said compounds are useful for treating hormone-related conditions including contraception, treating or prevent…
2011
Disclosed herein are oxazolidone compounds of the given formula wherein the substituents are as defined within the specification. Said compounds are useful for treating hormone-related conditions including contraception, treating or prevent…
2011
Disclosed herein are oxazolidone compounds of the given formula wherein the substituents are as defined within the specification. Said compounds are useful for treating hormone-related conditions including contraception, treating or prevent…
2011
Disclosed herein are oxazolidone compounds of the given formula wherein the substituents are as defined within the specification. Said compounds are useful for treating hormone-related conditions including contraception, treating or prevent…
2011
Disclosed herein are oxazolidone compounds of the given formula wherein the substituents are as defined within the specification. Said compounds are useful for treating hormone-related conditions including contraception, treating or prevent…
2011
Disclosed herein are oxazolidone compounds of the given formula wherein the substituents are as defined within the specification. Said compounds are useful for treating hormone-related conditions including contraception, treating or prevent…
2011
Disclosed herein are oxazolidone compounds of the given formula wherein the substituents are as defined within the specification. Said compounds are useful for treating hormone-related conditions including contraception, treating or prevent…
2011
Disclosed herein are oxazolidone compounds of the given formula wherein the substituents are as defined within the specification. Said compounds are useful for treating hormone-related conditions including contraception, treating or prevent…
2010
In one embodiment, compounds of the following structure are described, wherein R1 to R7 are described herein. Also provided are methods for preparing these compounds and methods of contraception treating or preventing fibroids treating or p…
2010
In one embodiment, compounds of the following structure are described, wherein R1 to R7 are described herein. Also provided are methods for preparing these compounds and methods of contraception treating or preventing fibroids treating or p…
2010
In one embodiment, compounds of the following structure are described, wherein R1 to R7 are described herein. Also provided are methods for preparing these compounds and methods of contraception treating or preventing fibroids treating or p…
2010
In one embodiment, compounds of the following structure are described, wherein R1 to R7 are described herein. Also provided are methods for preparing these compounds and methods of contraception treating or preventing fibroids treating or p…
2010
In one embodiment, compounds of the following structure are described, wherein R1 to R7 are described herein. Also provided are methods for preparing these compounds and methods of contraception treating or preventing fibroids treating or p…
2010
In one embodiment, compounds of the following structure are described, wherein R1 to R7 are described herein. Also provided are methods for preparing these compounds and methods of contraception treating or preventing fibroids treating or p…
2010
In one embodiment, compounds of the following structure are described, wherein R1 to R7 are described herein. Also provided are methods for preparing these compounds and methods of contraception treating or preventing fibroids treating or p…
2010
In one embodiment, compounds of the following structure are described, wherein R1 to R7 are described herein. Also provided are methods for preparing these compounds and methods of contraception treating or preventing fibroids treating or p…
2010
In one embodiment, compounds of the following structure are described, wherein R1 to R7 are described herein. Also provided are methods for preparing these compounds and methods of contraception treating or preventing fibroids treating or p…
2010
Compounds of the following structure are provided, wherein n, R1-R3 and R6-R9 are defined below, as are methods of preparing and using these compounds for contraception treating or preventing fibroids, uterine leiomyomata, endometriosis, dy…
2010
Compounds of the following structure are provided, wherein n, R1-R3 and R6-R9 are defined below, as are methods of preparing and using these compounds for contraception treating or preventing fibroids, uterine leiomyomata, endometriosis, dy…
2010
Compounds of the following structure are provided, wherein n, R1-R3 and R6-R9 are defined below, as are methods of preparing and using these compounds for contraception treating or preventing fibroids, uterine leiomyomata, endometriosis, dy…
2010
Compounds of the following structure are provided, wherein n, R1-R3 and R6-R9 are defined below, as are methods of preparing and using these compounds for contraception treating or preventing fibroids, uterine leiomyomata, endometriosis, dy…
2010
Compounds of the following structure are provided, wherein n, R1-R3 and R6-R9 are defined below, as are methods of preparing and using these compounds for contraception treating or preventing fibroids, uterine leiomyomata, endometriosis, dy…
2010
Compounds of the following structure are provided, wherein n, R1-R3 and R6-R9 are defined below, as are methods of preparing and using these compounds for contraception treating or preventing fibroids, uterine leiomyomata, endometriosis, dy…
2010
Compounds of the following structure are provided, wherein n, R1-R3 and R6-R9 are defined below, as are methods of preparing and using these compounds for contraception treating or preventing fibroids, uterine leiomyomata, endometriosis, dy…